The Fund’s objective is to provide long-term capital growth by investing primarily in equity securities anywhere in the world.
Invests in the equity securities of global companies with an Absolute Value focus.
| Inception Date | December 30, 2014 |
| Currency | CAD |
| Fund AUM | $10.1 Million |
| NAVPU | $12.75 |
| Management Fee | 1.80% |
| MER as of December 31, 2021 | 2.13% |
| Minimum Initial Investment | $1,000 |
| Minimum Subsequent Investment | $100 |
| Liquidity | Daily |
| RRSP Eligible | Yes |
| Number of Securities | 14 |
| Dividend Yield | 2.1% |
▲The NAVs posted are post-distribution.
| Security | % of fund | |
|---|---|---|
| CANADA T-BILL | 66.5% | |
| Honda Motor Co. Ltd. ADR | 5.1% | |
| Verizon Communications Inc. | 4.5% | |
| Linamar Corp | 4.0% | |
| Canadian Natural Resources | 3.6% | |
| Cdn. Utilities Ltd. | 2.8% | |
| Bank of Nova Scotia | 2.4% | |
| Bank of Montreal | 1.9% | |
| Toronto Dominion Bank | 1.8% | |
| Royal Bank of Canada | 1.8% | |
| Total | 94.4% |
| Distribution Frequency: Quarterly |
| Most Recent Distribution per Unit: $0.0269 |
| 12-Month Trailing Distribution Yield: 21.9% |
| Next Record Date: June 23, 2022 |
| Next Distribution Date: June 24, 2022 |
| Record Date | Distribution Date |
|---|---|
| March 24, 2022 | March 25, 2022 |
| June 23, 2022 | June 24, 2022 |
| September 29, 2022 | September 30, 2022 |
| December 29, 2022 | December 30, 2022 |
| Distributions ($)/Unit2 | YTD* | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| Total Distributions | 0.0269 | 2.7860 | 0.0619 | 0.6172 | 0.0456 | 0.0373 | 0.0216 | 0.0000 |
| Interest | 0.0000 | 0.0000 | ||||||
| Dividends | 0.2033 | 0.0619 | 0.1721 | 0.0382 | 0.0373 | 0.0216 | ||
| Capital Gains | 2.5827 | 0.0000 | 0.4451 | 0.0074 | ||||
| Withholding Tax | 0.0000 | 0.0000 |
*The final tax character will be determined based on the Fund’s tax year end information
Lysander Funds Limited is the investment fund manager of Lysander Patient Capital Equity Fund (the “Fund”). This
document is not an invitation to invest in the Fund and does not constitute a public offering of sale. Purchases in the Fund can only be
made through an Investment Professional on the terms in the Fund’s offering document by eligible investors. Each purchaser of units in a
fund may have statutory or contractual right of action. Commissions, trailing commissions, management fees and expenses all may be
associated with mutual fund investments. Please read the prospectus before investing. The indicated rates of return are historical annual
compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account sales,
redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Mutual
funds are not guaranteed or insured, their values change frequently and past performance may not be repeated. 1Source: TSX © Copyright
2021 TSX Inc. All Rights Reserved. 2Distributions are based on the actual number of units outstanding at the relevant time. Distributions are
paid in cash or reinvested in additional units. If the series’ net income/capital gains is less than the amounts distributed in the year,
the distribution will include a return of capital. In these circumstances, if an investor elects to receive their distributions in cash and not
reinvest distributions, it is expected that the value of their investment will decline over time. Distributions are not an indication of
performance, rate of return or yield. On November 1, 2021, the portfolio manager of the fund changed from 18 Asset Management Inc. to Patient Capital Management Inc. and the investment objective of the fund no longer had a Canadian equity securities focus. These changes could have affected the performance of the fund had these changes been in effect throughout the performance measurement period. ®Lysander Funds is a registered trademark of Lysander Funds Limited.
We have updated our Privacy Policy effective October 2021. We encourage you to review it carefully.
We use cookies to improve your experience. By continuing to use this website, or other online services, you agree to the use of cookies and consent to the practices described in our Privacy Policy and Terms of Use.